← Leaderboards
Ying He
University Of Illinois At Chicago
$2,536,105
Attributed
$2,536,105
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,536,105 · 3
By mechanism
RF1$1,764,145 · 1
R00$497,996 · 1
K99$273,964 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Karyn Ann Esser$18,858,503
- Zaijie Jim Wang$13,634,711
- Santosh Saraf$5,561,155
- Nissim Hay$25,480,567
- Stephanie M Cologna$6,486,179
Others in their field
Other Emerging Leaders on “Maps”
- Jacob Ruff · Cornell University$22,500,000
- Leonard Freedman · Leidos Biomedical Research, Inc.$21,750,066
- Rui M. Costa · Columbia University Health Sciences$19,333,042
- Peter John Hunter · University Of Auckland$16,320,924
- Badri N Vardarajan · University Of Miami School Of Medicine$16,083,856
- Andrew Shoffstall · Louis Stokes Cleveland Va Medical Center$15,790,088
Research focus
MapsMicrornasExosomeKnock-DownAfricanMedicalDisease ProgressionEpigenetic ProcessGene ExpressionHemolytic AnemiaBiogenesisBiological MarkersAcute PainMediatingChronic PainAdultAcuteCompanionsAmericanAffectBehavioral ParadigmDoseDesignMolecular
Grant awards (5)
MicroRNA as a Novel Therapeutic Target for Pain in Sickle Cell Disease$1,764,145
RF1 · FY2025 · NS · contact PI
MicroRNA as a target for fetal hemoglobin inducing agents in sickle cell disease$248,998
R00 · FY2022 · HL · contact PI
MicroRNA as a target for fetal hemoglobin inducing agents in sickle cell disease$248,998
R00 · FY2021 · HL · contact PI
MicroRNA as a target for fetal hemoglobin inducing agents in sickle cell disease$136,982
K99 · FY2018 · HL · contact PI
MicroRNA as a target for fetal hemoglobin inducing agents in sickle cell disease$136,982
K99 · FY2017 · HL · contact PI